Zobrazeno 1 - 10
of 417
pro vyhledávání: '"Sulahian R"'
Autor:
Sulahian, R1, Casey, F2, Shen, J2, Qian, Z R3, Shin, H4, Ogino, S3, Weir, B A5, Vazquez, F5, Liu, X S4, Hahn, W C6, Bass, A J6, Chan, V2, Shivdasani, R A6
Publikováno v:
Oncogene. 12/4/2014, Vol. 33 Issue 49, p5637-5648. 12p. 8 Graphs.
Autor:
Kim M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Ly SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Xie Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Duronio GN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ford-Roshon D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Hwang JH; Masonic Cancer Center and Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA., Sulahian R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Rennhack JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., So J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Gjoerup O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Talamas JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Grandclaudon M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Sethi NS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: william_hahn@dfci.harvard.edu.
Publikováno v:
Developmental cell [Dev Cell] 2022 Jan 24; Vol. 57 (2), pp. 212-227.e8. Date of Electronic Publication: 2022 Jan 05.
Autor:
Waters AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Khatib TO; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Papke B; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Goodwin CM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Hobbs GA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Diehl JN; Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Yang R; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Edwards AC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Walsh KH; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Sulahian R; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., McFarland JM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Kapner KS; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gilbert TSK; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; UNC Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Stalnecker CA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Javaid S; Oral and Craniofacial Biomedicine PhD Program, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Barkovskaya A; Institute for Cancer Research, Oslo University Hospital, Oslo 0379, Norway., Grover KR; Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Hibshman PS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Blake DR; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Schaefer A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Nowak KM; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Klomp JE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Hayes TK; Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Kassner M; Cancer and Cell Biology Division, Translational Genomic Research Institute, Phoenix, AZ 85004, USA., Tang N; Cancer and Cell Biology Division, Translational Genomic Research Institute, Phoenix, AZ 85004, USA., Tanaseichuk O; Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA., Chen K; Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA., Zhou Y; Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA., Kalkat M; Department of Medical Biophysics, University of Toronto, Toronto, ON M5S, Canada., Herring LE; UNC Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Graves LM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Penn LZ; Department of Medical Biophysics, University of Toronto, Toronto, ON M5S, Canada., Yin HH; Cancer and Cell Biology Division, Translational Genomic Research Institute, Phoenix, AZ 85004, USA., Aguirre AJ; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Brigham and Women's Hospital, Boston, MA 02215, USA., Hahn WC; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Brigham and Women's Hospital, Boston, MA 02215, USA., Cox AD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Oral and Craniofacial Biomedicine PhD Program, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Der CJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Oral and Craniofacial Biomedicine PhD Program, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: cjder@med.unc.edu.
Publikováno v:
Cell reports [Cell Rep] 2021 Jun 29; Vol. 35 (13), pp. 109291.
Autor:
Ghadrdoost Nakhchi, Behshid1 (AUTHOR) bghadrdoostnakhchi@versiti.org, Kosuru, Ramoji1 (AUTHOR), Chrzanowska, Magdalena1,2,3,4 (AUTHOR) mchrzanowska@versiti.org
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p9853. 21p.
Autor:
Ferguson FM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Liu Y; Departments of Biochemistry and Radiation Oncology, the University of Texas Southwestern Medical Center, Dallas, TX, USA., Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Kuljanin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kalekar RL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., He S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Ng RWS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sulahian R; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Li L; Departments of Biochemistry and Radiation Oncology, the University of Texas Southwestern Medical Center, Dallas, TX, USA., Poulin EJ; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Huang L; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Koren J; Department of Molecular and Human Genetics, Therapeutic Innovation Center Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA., Dieguez-Martinez N; Departament de Bioquímica i Biologia Molecular & Institut de Neurociencies, Facultat de Medicina. Universitat Autonoma de Barcelona, Bellaterra, Spain., Espinosa S; Departament de Bioquímica i Biologia Molecular & Institut de Neurociencies, Facultat de Medicina. Universitat Autonoma de Barcelona, Bellaterra, Spain., Zeng Z; Promega Corporation, Madison, WI, USA., Corona CR; Promega Corporation, Madison, WI, USA., Vasta JD; Promega Corporation, Madison, WI, USA., Ohi R; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA., Sim T; Chemical Kinomics Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea and KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea., Kim ND; NDBio Therapeutics Inc, Incheon, Republic of Korea., Harshbarger W; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; GSK Vaccines, Rockville, MD, USA., Lizcano JM; Departament de Bioquímica i Biologia Molecular & Institut de Neurociencies, Facultat de Medicina. Universitat Autonoma de Barcelona, Bellaterra, Spain., Robers MB; Promega Corporation, Madison, WI, USA., Muthaswamy S; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Departments of Medicine and Pathology, Harvard Medical School, Boston, MA, USA., Lin CY; Department of Molecular and Human Genetics, Therapeutic Innovation Center Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA., Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Haigis KM; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Digestive Disease Center, Harvard Medical School, Boston, MA, USA., Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Westover KD; Departments of Biochemistry and Radiation Oncology, the University of Texas Southwestern Medical Center, Dallas, TX, USA., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2020 Jun; Vol. 16 (6), pp. 635-643. Date of Electronic Publication: 2020 Apr 06.
Autor:
Weihong Zhang1,2, Shilong Wang2, Hui Zhang2, Yan Meng1, Shi Jiao2, Liwei An1 lwan@tongji.edu.cn, Zhaocai Zhou2,3 zhouzhaocai@fudan.edu.cn
Publikováno v:
Cancer Biology & Medicine. Jul2024, Vol. 21 Issue 7, p553-570. 18p.
Autor:
Riccardi, Federico1 (AUTHOR), Romano, Giulia1 (AUTHOR), Licastro, Danilo2 (AUTHOR), Pagani, Franco1 (AUTHOR) pagani@icgeb.org
Publikováno v:
PLoS ONE. 6/3/2024, Vol. 19 Issue 6, p1-25. 25p.
Autor:
Sulahian R; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Kwon JJ; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Walsh KH; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Pailler E; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bosse TL; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Thaker M; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Almanza D; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Dempster JM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Pan J; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Piccioni F; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Dumont N; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Gonzalez A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Rennhack J; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Bachman JA; Laboratory of Systems Pharmacology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115, USA., Goodale A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Lee Y; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Bagul M; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Liao R; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Navarro A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Yuan TL; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Ng RWS; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Raghavan S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Tsherniak A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Vazquez F; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Firestone AJ; Calico Life Sciences, South San Francisco, CA 94080, USA., Settleman J; Calico Life Sciences, South San Francisco, CA 94080, USA., Hahn WC; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, MA. Electronic address: william_hahn@dfci.harvard.edu., Aguirre AJ; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, MA. Electronic address: andrew_aguirre@dfci.harvard.edu.
Publikováno v:
Cell reports [Cell Rep] 2019 Oct 01; Vol. 29 (1), pp. 118-134.e8.
Autor:
Saxena M; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Roman AKS; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts 02215, USA., O'Neill NK; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA., Sulahian R; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Jadhav U; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Shivdasani RA; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Harvard Stem Cell Institute, Cambridge, Massachusetts 02139, USA.
Publikováno v:
Genes & development [Genes Dev] 2017 Dec 01; Vol. 31 (23-24), pp. 2391-2404. Date of Electronic Publication: 2018 Jan 10.
Autor:
Qian Zhang1, Mingran Yang1, Peng Zhang1, Bowen Wu1, Xiaosen Wei1, Shao Li1 shaoli@tsinghua.edu.cn
Publikováno v:
Cancer Biology & Medicine. Apr2024, Vol. 21 Issue 4, p312-330. 19p.